MedicaidCoverageMedium impact
BT2024142: IHCP adds coverage for Releuko (Q5125)
Indiana Medicaid (IHCP)·IN · Oncology, Hematology·Medical Policy
Effective date
Nov 22, 2022
We identified it
Jun 19, 2026
Summary
IHCP (Indiana Medicaid) has added coverage for Releuko injection (Q5125) effective immediately, retroactive to November 22, 2022. The drug requires NDC codes on all claims and no prior authorization is needed.
Action Required
Immediately: Billing team can now submit claims for Q5125 (Releuko injection) to Indiana Medicaid. Must include NDC codes on all claims. For institutional outpatient claims, bill with revenue code 636. Can resubmit previously denied claims within 90 days for managed care or 180 days for fee-for-service, including copy of this bulletin to satisfy timely filing requirements.